Omega-7, Skin Health, and Metabolic Benefits

Evidence Review

Geng et al. 2022 — Systematic Review and Meta-Analysis (Metabolic Syndrome)

This meta-analysis [1] in Phytotherapy Research is the most comprehensive synthesis of sea buckthorn's effects on cardiometabolic risk factors. The analysis included 15 randomized controlled trials with diverse populations and preparations.

Key findings:

• Triglycerides: SMD –0.722 (95% CI: –1.046 to –0.399, P < 0.001) — statistically significant reduction
• Total cholesterol: SMD –0.345 (P < 0.001)
• LDL cholesterol: SMD –0.396 (P < 0.001)
• HDL cholesterol: SMD +0.370 (P < 0.001)
• No significant effects on fasting glucose, HbA1c, blood pressure, or BMI in the pooled analysis

Limitations: High heterogeneity (I² 79–90%) across included trials, reflecting differences in preparation (berries vs. oil vs. juice), dose, population, and duration. The authors found that lipid benefits were concentrated in participants with abnormal baseline values — a pattern consistent with corrective rather than pharmacological action. Most included trials were moderate quality; no trial was rated high quality by standard risk-of-bias assessment.

Interpretation: The consistent direction of lipid benefit across 15 trials with diverse preparations is reassuring, but the heterogeneity limits precision on optimal dose and form. The baseline-dependent effect is a practical signal for who is most likely to benefit.

Larmo et al. 2008 — Double-Blind RCT (Inflammation and Infection)

This trial [2] randomized 254 healthy Finnish adults to sea buckthorn berry supplementation or placebo for 90 days. It is the primary human evidence for sea buckthorn's anti-inflammatory effect.

Design: 254 enrolled, 233 completed. Placebo-controlled, double-blind. Primary endpoints: incidence and severity of cold and GI infections. Secondary endpoints: inflammatory markers including CRP.

Results:

• No significant reduction in cold or GI infection rates (the primary endpoint was not met)
• CRP: sea buckthorn group showed a significant reduction vs. placebo (median change difference –0.059 mg/L, P = 0.039)
• No significant effects on other measured inflammatory markers

Interpretation: The trial failed its primary efficacy endpoint but found a meaningful CRP reduction — a clinically relevant secondary finding. The authors note that a 90-day trial in healthy adults is a difficult design for demonstrating infection rate reduction. The CRP finding suggests real anti-inflammatory activity even in a healthy population without elevated baseline inflammation, which is notable. The study is well-designed with adequate power for the primary outcome, adding credibility to the CRP result as a genuine secondary finding rather than a spurious one.

Larmo et al. 2010 — Double-Blind RCT (Dry Eye)

This trial [3] in the Journal of Nutrition is the most direct test of sea buckthorn oil's mucosal omega-7 hypothesis. One hundred participants with dry eye symptoms were randomized to 2 g/day sea buckthorn oil or placebo for 3 months.

Design: 100 enrolled, 86 completed (intent-to-treat analysis for primary outcomes). Outcome measures: tear film osmolarity (primary), ocular surface symptoms including redness and burning.

Results:

• Tear film osmolarity: the seasonal increase in osmolarity (a dry eye progression marker) was significantly attenuated in the sea buckthorn group vs. placebo (P < 0.05)
• Redness: significantly reduced in the sea buckthorn group in intent-to-treat analysis
• Burning sensation: significantly reduced in per-protocol analysis
• Tear production (Schirmer test): no significant change

Interpretation: This is a clean, well-designed trial in an area where few effective nutritional interventions exist. The mechanism — dietary palmitoleic acid improving meibomian gland lipid composition and thus stabilizing the tear film — is biologically plausible and supported by the trial's positive outcome. The finding that tear production was unchanged while osmolarity (concentration) was reduced points to improved evaporation resistance (a lipid layer effect) rather than increased aqueous output, consistent with the omega-7 mechanism.

Ciesarová et al. 2020 — Comprehensive Composition Review

This review [4] in Food Research International synthesizes the phytochemical literature on sea buckthorn's composition across berries, leaves, seed, and pulp oil. It is the best single reference for claims about nutritional content.

Key compositional facts documented:

• Vitamin C: 120–695 mg/100 g fresh weight (variance by subspecies and growing conditions); consistently among the highest of any fruit, exceeding rosehip and far exceeding citrus
• Carotenoids: 30–300 mg/100 g in pulp, primarily beta-carotene, lycopene, zeaxanthin, and lutein — the orange colour is an index of carotenoid density
• Tocopherols: 100–900 mg/kg in pulp oil — among the highest of any plant oil
• Palmitoleic acid (omega-7): 17–32% of fatty acids in pulp oil; negligible in seed oil
• Polyphenols: isorhamnetin, quercetin, kaempferol (flavonols); proanthocyanidins; ellagitannins; phenolic acids

Significance for interpreting trial results: The wide compositional ranges explain some of the heterogeneity in clinical trials — a preparation from one subspecies at one dose may deliver 10-fold more active compounds than another. Standardization of sea buckthorn products by key active constituents (particularly omega-7 content, carotenoid content, or vitamin C content) would substantially improve research precision.

Mortensen et al. 2018 — Randomized Crossover (Glycaemic Response)

This crossover study [5] in the European Journal of Nutrition tested sea buckthorn puree's effect on postprandial glucose and insulin in 18 overweight/obese men.

Design: Four-arm crossover (sea buckthorn, strawberry, sugar solution with matched sucrose, inulin control), with standardized sucrose-containing meals. Outcome: postprandial glucose and insulin area under the curve (AUC) at 30, 60, 90, and 120 minutes.

Results:

• Postprandial insulin at 30 minutes: reduced 39.6% vs. control (P < 0.05)
• Glycaemic profile AUC: improved 44.7% vs. control (P < 0.05)
• Strawberry meal: no significant effect on insulin or glucose AUC
• Time to peak insulin: significantly delayed in sea buckthorn group

Interpretation: The effect is specific to sea buckthorn rather than berries in general (strawberry showed nothing). The proposed mechanism — polyphenol-mediated inhibition of alpha-glucosidase and alpha-amylase (enzymes that digest carbohydrates in the gut) — is supported by in vitro data and consistent with the delayed rather than just blunted insulin peak. For people managing blood sugar, consuming sea buckthorn alongside carbohydrate-containing foods could have practical benefit, though this single crossover trial needs replication. Note the population (obese men) may not generalize to all groups.

Yang et al. 1999 — Randomized Trial (Atopic Dermatitis)

This trial [6] in the Journal of Nutritional Biochemistry is the primary human evidence for sea buckthorn's skin benefit. Forty-nine patients with confirmed atopic dermatitis were randomized to sea buckthorn pulp oil, seed oil, or placebo for 4 months.

Results:

• Pulp oil group: significant improvement in dermatitis severity (P < 0.01, clinical scoring by dermatologist)
• Seed oil group: improvement trend but not statistically significant (P = 0.11)
• Pulp oil group: significant increase in HDL cholesterol (1.38 → 1.53 mmol/L, P < 0.05)

Significance: The difference between pulp oil and seed oil is mechanistically informative. The oils have substantially different fatty acid profiles: pulp oil is rich in palmitoleic acid (omega-7, ~25%), whereas seed oil contains primarily linoleic acid (omega-6) and alpha-linolenic acid (omega-3) with minimal omega-7. The superior performance of pulp oil in dermatitis — an inflammatory skin barrier disorder — points to palmitoleic acid specifically as the active constituent for skin outcomes. The HDL improvement in the pulp oil group, absent in the seed oil group, is consistent with omega-7's known lipid-modulating effects.

Evidence Strength Summary

Lipid improvement (dyslipidemia): Strong — 15 RCTs in meta-analysis with consistent direction; effects are selective for those with abnormal baseline lipids. Confidence: high for people with elevated lipids; low for those with normal lipids.

Anti-inflammatory (CRP): Moderate — one well-designed RCT confirming CRP reduction in healthy adults; secondary finding, not primary endpoint. Confidence: moderate.

Dry eye and mucosal health (omega-7): Moderate to high — one well-designed RCT in dry eye with positive primary and secondary outcomes; strong mechanistic rationale. Confidence: moderate-to-high.

Skin health / atopic dermatitis: Moderate — one RCT in atopic dermatitis patients showing pulp oil benefit; small sample (n=49), but mechanistically consistent with omega-7 composition data. Confidence: moderate.

Glycaemic response: Low to moderate — single crossover trial with promising results; needs replication in larger, more diverse populations. Confidence: low-to-moderate.

Overall, sea buckthorn has a broad but moderately sized evidence base. No single effect is supported by the kind of multiple large independent trials that define high-confidence nutrition research, but the consistent direction across diverse populations and preparations is encouraging. The lipid and dry eye evidence are the most actionable for most people.